Logo image
Immunology of systemic sclerosis
Journal article   Open access   Peer reviewed

Immunology of systemic sclerosis

Carol M Artlett
Frontiers in bioscience, v 10(2), pp 1707-1719
01 May 2005
PMID: 15769660
url
https://www.imrpress.com/journal/FBL/10/2/10.2741/1654/pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.2741/1654View
Published, Version of Record (VoR) Open

Abstract

Antibody Formation HLA Antigens - genetics Humans Immunity, Cellular Scleroderma, Systemic - epidemiology Scleroderma, Systemic - immunology Scleroderma, Systemic - physiopathology Scleroderma, Systemic - virology T-Lymphocytes - immunology
Systemic sclerosis (scleroderma; SSc) is an autoimmune disorder of unknown etiology characterized by severe and progressive cutaneous and visceral fibrosis, pronounced alterations in the microvasculature, and numerous cellular and humoral immunological abnormalities. Clinically, systemic sclerosis is very heterogeneous, ranging from mild limited forms of skin sclerosis (LcSSc) with minimal internal organ involvement to severe skin to multiple internal organ fibrosis and extensive skin fibrosis (DcSSc). Mortality and morbidity in systemic sclerosis is very high and are directly related to the extent of the fibrotic and microvascular alterations. The interactions between blood vessels, fibroblast activity, and immunological processes play an important role in the pathogenesis of SSc.

Metrics

17 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemistry & Molecular Biology
Cell Biology
Logo image